SFX by Ex Libris Inc.

Title:	A model for diabetic nephropathy: Advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse
Source:	Journal of Cellular Physiology [0021-9541] Inada, Akari yr:2008

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Allen, Terri J J. "Rodent models of streptozotocin-induced diabetic nephropathy." Nephrology 12.3 (2007): 261-6.
description	2.	Shertzer HG, Schneider SN, Kendig EL, Clegg DJ, D', H. "Acetaminophen normalizes glucose homeostasis in mouse models for diabetes." Biochemical Pharmacology 75.6 (2008): 1402-1410.
description	3.	Tesch, Gregory H H. "Recent insights into experimental mouse models of diabetic nephropathy." Nephron. Experimental nephrology 104.2 (2006): 57-62.
description	4.	Rees, D A A. "Animal models of diabetes mellitus." Diabetic medicine 22.4: 359-370.
description	5.	Woods, Stephen C. C. "A controlled high-fat diet induces an obese syndrome in rats." The Journal of nutrition 133.4 (2003): 1081-7.
description	6.	Sharma, K. "Mouse models of diabetic nephropathy." Journal of the American Society of Nephrology 16.1 (2004): 27-45.
description	7.	Martinez-Olivares, R. "Depletion and recovery of catecholamines in several organs of rats treated with reserpine." Autonomic neuroscience 128.1-2 (2006): 64-9.
description	8.	Miller, Richard A A. "Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance." Aging cell 4.3 (2005): 119-25.
description	9.	Tesch, Greg H H. "Rodent models of streptozotocin-induced diabetic nephropathy (Methods in Renal Research)." Nephrology 12.3 (2007): 261-6.
description	10.	Nath, C. "Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice." European Journal of Pharmacology 581.3 (2008): 283-9.
description	11.	Tanja Birrenbach, T. "Inflammatory Bowel Disease and Smoking: A Review of Epidemiology, Pathophysiology, and Therapeutic Implications." Inflammatory bowel diseases 10.6: 848-859.
description	12.	Civitarese AE, Anthony E E. "Diet, energy metabolism and mitochondrial biogenesis." Current opinion in clinical nutrition and metabolic care 10.6 (2007): 679-87.
description	13.	Cefalu, William T T. "Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition." ILAR journal 47.3 (2006): 186-98.
description	14.	Mordes, J P A. "Animal models of diabetes." The American journal of medicine 70.2 (1981): 353-360.
description	15.	Srinivasan, K. "Animal models in type 2 diabetes research: An overview." The Indian journal of medical research 125.3 (2007): 451-472.
description	16.	Danese, S. "Inflammatory bowel disease: the role of environmental factors." Autoimmunity reviews 3.5 (2004): 394-400.
description	17.	Luo, J. "Nongenetic mouse models of non-insulin-dependent diabetes mellitus." Metabolism, clinical and experimental 47.6: 663-668.
description	18.	Qi, Z. "Characterization of susceptibility of inbred mouse strains to diabetic nephropathy." Diabetes 54.9 (2005): 2628-2637.
description	19.	Binion, M. "Geriatric Inflammatory Bowel Disease: Phenotypic Presentation, Treatment Patterns, Nutritional Status, Outcomes, and Comorbidity." Digestive diseases and sciences 57.9 (2012): 2408-2415.
description	20.	Yotsumoto, T. "A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation." Metabolism, clinical and experimental 52.12 (2003): 1633-7.